U.S. Global Investors (USGI)’s CVS Health CVS Stock Holding History

U.S. Global Investors (USGI)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,800	Closed	-$276K	–	115
2017 Q4	$276K	Sell	3,800 -2,700	-42%	-$196K	0.13%	107
2017 Q3	$529K	Buy	+6,500	New	+$514K	0.16%	97
2017 Q2	–	Sell	-5,681	Closed	-$446	–	151
2017 Q1	$446	Sell	5,681 -1,144	-17%	-$91.3K	﹤0.01%	104
2016 Q4	$539K	Buy	6,825 +2,100	+44%	+$170K	0.23%	85
2016 Q3	$420K	Buy	4,725 +759	+19%	+$71.6K	0.2%	107
2016 Q2	$380K	Sell	3,966 -3,312	-46%	-$330K	0.21%	112
2016 Q1	$755K	Buy	7,278 +2,278	+46%	+$222K	0.41%	93
2015 Q4	$489K	Sell	5,000 -10,000	-67%	-$979K	0.26%	112
2015 Q3	$1.45M	Buy	15,000 +2,400	+19%	+$252K	0.77%	45
2015 Q2	$1.32M	Buy	12,600 +10,000	+385%	+$1.02M	0.51%	55
2015 Q1	$268K	Hold	2,600	–	–	0.07%	194
2014 Q4	$250K	Buy	+2,600	New	+$229K	0.07%	197
2014 Q1	–	Sell	-4,000	Closed	-$286K	–	324
2013 Q4	$286K	Sell	4,000 -1,440	-26%	-$92.5K	0.05%	202
2013 Q3	$309K	Buy	+5,440	New	+$324K	0.05%	181

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Global Investors (USGI)'s CVS Position: Q1 2018 in Review

U.S. Global Investors (USGI) sold out of CVS Health (CVS) in Q1 2018, closing a stake of 3,800 shares — an estimated $276K sold.

U.S. Global Investors (USGI) first reported a position in CVS in Q3 2013 and held it in 14 quarters. The position peaked at $1.45M in Q3 2015. 1,549 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

U.S. Global Investors (USGI) reported no remaining CVS Health position as of Q1 2018 after selling out during the quarter.
U.S. Global Investors (USGI) sold 3,800 CVS Health shares in Q1 2018, an estimated $276K.
U.S. Global Investors (USGI) first reported a position in CVS Health in Q3 2013 and held it in 14 quarters.
U.S. Global Investors (USGI)'s CVS Health position peaked at $1.45M in Q3 2015.
1,549 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2018, filed 15 May 2018.